More about

Diabetic Macular Edema

CME
Video

Rapid Response From Angiogenesis 2025: Advances in Treating Diabetic Macular Edema

Rapid Response From Angiogenesis 2025: Advances in Treating Diabetic Macular Edema
1.00 CME
60 MINS
$0 FEE
News
March 07, 2025
13 min read
Save

Connection emerging between obstructive sleep apnea, ocular conditions

Connection emerging between obstructive sleep apnea, ocular conditions

Obstructive sleep apnea is a common breathing-related sleep disorder, with a growing prevalence due to the aging population and the rise of obesity.

CME
Video

Retinal Disease Digest on DME: Opportunities for Optometrists

Retinal Disease Digest on DME: Opportunities for Optometrists
1.00 COPE
60 MINS
$0 FEE
News
March 03, 2025
1 min read
Save

Older patients with DME have weaker response to anti-VEGF treatment

Older patients with DME have weaker response to anti-VEGF treatment

Older patients with diabetic macular edema have a weaker response to anti-VEGF treatment, according to a presentation at Angiogenesis, Exudation, and Degeneration 2025.

News
February 13, 2025
2 min read
Save

Dual inhibition with faricimab improves disease control in DME, neovascular AMD

Dual inhibition with faricimab improves disease control in DME, neovascular AMD

Faricimab demonstrated noninferior vision gains and improved anatomical outcomes among patients with diabetic macular edema and neovascular age-related macular degeneration vs. aflibercept, according to study data.

News
February 06, 2025
2 min read
Save

Duravyu for DME meets primary, secondary endpoints in phase 2 trial

Duravyu for DME meets primary, secondary endpoints in phase 2 trial

Duravyu at two dose levels met its primary endpoint in the treatment of diabetic macular edema in a phase 2 clinical trial, according to a press release from EyePoint Pharmaceuticals.

News
February 05, 2025
2 min watch
Save

VIDEO: Positive data reported on OCS-05 in acute optic neuritis

VIDEO: Positive data reported on OCS-05 in acute optic neuritis

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, Riad Sherif, MD, CEO of Oculis, discusses data on OCS-05 for the treatment of acute optic neuritis.

News
February 04, 2025
1 min read
Save

FDA approves Susvimo for diabetic macular edema

FDA approves Susvimo for diabetic macular edema

The FDA approved Susvimo for the treatment of diabetic macular edema, according to a press release.

News
January 24, 2025
5 min watch
Save

VIDEO: OTX-TKI moves toward phase 3 trial for treatment of diabetic retinopathy

VIDEO: OTX-TKI moves toward phase 3 trial for treatment of diabetic retinopathy

KOLOA, Hawaii — In this Healio Video Perspective from Retina 2025, Peter K. Kaiser, MD, of Ocular Therapeutix, discusses positive data for OTX-TKI, a tyrosine kinase inhibitor designed to block VEGFR-1, VEGFR-2 and VEGFR-3.

News
January 13, 2025
2 min read
Save

4D-150 for DME moving to phase 3 trial following positive interim data

4D-150 for DME moving to phase 3 trial following positive interim data

4D Molecular Therapeutics reported positive interim data from the first part of the SPECTRA clinical trial investigating 4D-150 in patients with diabetic macular edema, according to a press release.

View more